An experience of oseltamivir phosphate (Tamiflu™) in a pediatric patient with chronic idiopathic thrombocytopenic purpura: A case report

Pathophysiology of Haemostasis and Thrombosis

Volumn 37, Issue 2-4, 2009, Pages 55-58

  Alioglu, Bulent ^a   Tasar, Aysin ^a   Ozen, Cinar ^a   Selver, Beray ^a   Dallar, Yildiz ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

H1N1; Idiopathic thrombocytopenic purpura; Influenza A; Oseltamivir phosphate

Indexed keywords

OSELTAMIVIR;

ADOLESCENT; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFLUENZA A (H1N1); PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADOLESCENT; ANTIVIRAL AGENTS; CHRONIC DISEASE; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; OSELTAMIVIR; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 79957962293     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000321379     Document Type: Article

References (14)

1. Rand ML, Wright JF: Virus-associated idiopathic thrombocytopenic purpura. Transfus Sci 1998; 19: 253-259.
2. Rice J, Resar LM: Hematologic abnormalities associated with influenza A infection: A report of 3 cases. Am J Med Sci 1998; 316: 401-403. (Pubitemid 29019596)
3. Kelton JG: Vaccination-associated relapse of immune thrombocytopenia. JAMA 1981; 245: 369-371.
4. Mayer JL, Beardsley DS: Varicella-associated thrombocytopenia: Autoantibodies against platelet surface glycoprotein V. Pediatr Res 1996; 40: 615-619. (Pubitemid 26332591)
5. Karupiah G, Sacks TE, Klinman DM, Fredrickson TN, Hartley JW, Chen JH, et al: Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4+ T cells and CD40. Virology 1998; 240: 12-26. (Pubitemid 28394119)
6. Kaneko H, Ohkawara Y, Nomura K, Horiike S, Taniwaki M: Relapse of ITP caused by influenza A virus infection: A case report. J Infect Chemother 2004; 10: 364-366. (Pubitemid 40142829)
7. Fujita H: Idiopathic thrombocytopenic purpura following viral infection (in Japanese). Nippon Rinsho 2003; 61: 650-654.
8. Burch J, Corbett M, Stock C, et al: Prescription of anti-influenza drugs for healthy adults: A systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 537-545.
9. Lew W, Chen X, Kim CU: Discovery and development of GS 4104 (oseltamivir): An orally active influenza neuraminidase inhibitor. Curr Med Chem 2000; 7: 663-672. (Pubitemid 30396423)
10. Roche Laboratories Inc: Tamiflu product information. 2008. http://www.rocheusa.com/ products/tamiflu/pi.pdf (accessed May 15, 2009).
11. Crook M, Chin MA, Crawford N: Electrokinetic properties and surface membrane sialic acid status of platelets in idiopathic thrombocytopenic purpura (ITP). Br J Haematol 1991; 77: 209-214.
12. Crook M, Crawford N: Platelet surface charge heterogeneity characterization of human platelet subpopulations separated by high voltage continuous flow electrophoresis. Br J Haematol 1988; 69: 265-273.
13. Crook M, Crawford N: Electrokinetic, analytical and functional heterogeneity of circulating human platelets: Separation of subpopulations by continuous flow electrophoresis after taxol stabilisation. Biochim Biophys Acta 1989; 1014: 26-39. (Pubitemid 19261595)
14. Clezardin P, McCregor JL, Dechavanne M, Clemetson KJ: Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis. Br J Haematol 1985; 60: 331-344. (Pubitemid 15090183)